The PCOS Hormone Cascade: How Insulin Drives Androgens (Full Diagram + Intervention Map)

PCOS looks like a tangle of unrelated symptoms (cycles, acne, hair, weight, fertility) but it is actually one upstream switch and a downstream cascade. Understanding the cascade is the difference between treating symptoms one by one and treating the underlying mechanism that produces all of them. This is the full diagram, every step, with the specific intervention points where diet, supplements, and medication actually act.

Step 1: Insulin resistance at the cellular level

The upstream switch in roughly 70% of PCOS cases is intrinsic insulin resistance. This is not the kind of insulin resistance that develops from obesity (though obesity worsens it). It is a cellular signaling problem that the 2013 Stepto et al. study confirmed using euglycemic-hyperinsulinaemic clamps in normal-weight PCOS women: insulin response was measurably blunted at the cellular level, independent of body weight.

Drivers of step 1:

• Genetic predisposition. Multiple genes implicated, no single PCOS gene.
• Diet pattern. Chronic high-glycemic-load eating drives sustained hyperinsulinemia, which downregulates insulin receptor sensitivity over time.
• Body composition. Visceral fat (the abdominal kind) is more metabolically active than subcutaneous fat and worsens insulin resistance disproportionately.
• Sleep. Even one night of partial sleep deprivation measurably reduces insulin sensitivity the next day.
• Chronic stress. Cortisol antagonises insulin action.
• Sedentary behaviour. Muscle is the largest insulin-sensitive tissue. Less muscle activity = less glucose pulled out of circulation = higher chronic insulin.

Interventions that act here: metformin (the most direct), inositol (via a parallel second-messenger pathway), strength training (rebuilds muscle insulin sensitivity over weeks), berberine (over-the-counter alternative to metformin), and weight loss when applicable.

Step 2: The pancreas compensates with hyperinsulinemia

When cells respond poorly to insulin, the pancreas secretes more insulin to compensate. Fasting insulin rises (often the first measurable PCOS marker on routine labs). Post-meal insulin spikes higher and stays elevated longer. This is called compensatory hyperinsulinemia.

For most PCOS women, blood glucose stays in the normal range for years while insulin runs chronically elevated. This is why a standard fasting glucose test often looks normal in PCOS even when the underlying metabolic dysfunction is significant. Fasting insulin, HOMA-IR, or a 2-hour glucose tolerance test with paired insulin values are more diagnostic.

Interventions that act here: low-glycemic-load diet (smaller post-meal insulin spikes), protein-first eating order (-29% glucose, -37% insulin per the 2015 Shukla Diabetes Care study), vinegar before meals, fiber-rich foods, and any of the step-1 interventions which reduce the insulin demand upstream.

Step 3: Liver SHBG production drops

The liver makes sex-hormone-binding globulin (SHBG), a protein that binds testosterone and estrogen in circulation. Insulin suppresses SHBG production. As insulin rises chronically (step 2), SHBG falls. This is one of the cleanest mechanistic links in the cascade — there is a direct dose-response between fasting insulin and SHBG level.

Why this matters: testosterone bound to SHBG is biologically inactive. Only the free (unbound) fraction reaches androgen receptors and produces effects. A 30% drop in SHBG with the same total testosterone produces a measurably higher free testosterone fraction. This is why women with PCOS often have normal-looking total testosterone on labs but elevated free testosterone and clear hyperandrogenic symptoms.

SHBG is the most useful single lab marker for monitoring PCOS metabolic improvement. A rising SHBG over months of intervention is a reliable sign the upstream insulin pattern is moving in the right direction.

Step 4: Free testosterone rises in circulation

Lower SHBG plus normal-to-elevated total testosterone equals higher free testosterone. This is the active hormone fraction that drives:

• Hirsutism — terminal hair growth in androgen-sensitive areas (face, chest, abdomen, back).
• Androgenic alopecia — thinning hair on the scalp, often around the part line and crown.
• Sebaceous gland activation — the upstream cause of hormonal acne (jawline and chin pattern).
• Voice and body changes at very high androgen levels (rare in PCOS, more common in adrenal pathology).

Interventions that act here: spearmint tea (reduces theca cell androgen production downstream, see step 5), spironolactone (blocks androgen receptors), oral contraceptives containing anti-androgenic progestins (drospirenone, cyproterone), and any upstream intervention that raises SHBG.

Step 5: Ovarian theca cells overproduce androgens

The theca cells sit next to developing follicles and produce androstenedione, which is converted to testosterone and ultimately to estrogen in adjacent granulosa cells. Critically, theca cells have insulin receptors. When circulating insulin is chronically elevated (step 2), insulin directly stimulates the theca cells to make more androgens. This is a separate effect from the SHBG pathway in step 3.

The cumulative result of steps 3 and 5: more total androgen production AND more of that androgen in the free fraction. Both pathways converge on the same outcome — high biologically active testosterone.

This dual mechanism is part of why metformin and inositol (which act upstream on insulin) have downstream androgen-lowering effects even though they do not directly touch the ovary. Lower insulin = less direct theca stimulation + less SHBG suppression = less androgen in both production and active fraction.

Step 6: Follicle maturation arrests

Normal follicle development requires a precise balance of FSH and LH at the ovary, with the right ratio of androgen-to-estrogen in the local microenvironment. Excess androgens (from step 5) disrupt this. Follicles begin development but arrest at the small antral stage, accumulating without selecting a dominant follicle. On ultrasound, this is the classic polycystic morphology — 12 or more 2-9mm follicles on each ovary, sometimes called the "string of pearls" pattern.

Without a dominant follicle, ovulation does not occur. Without ovulation, the corpus luteum does not form. Without the corpus luteum, progesterone is not produced. Without progesterone, the endometrium does not shed on its normal monthly schedule, producing the irregular, infrequent, or absent periods that bring most PCOS women to a diagnosis.

Interventions that act here: inositol (improves FSH signaling at the ovary, restoring ovulation in 50-70% of anovulatory PCOS women per Unfer 2016), letrozole and clomiphene (pharmacologic ovulation induction), and any upstream intervention that reduces androgen exposure to the developing follicles.

Step 7: Visible symptoms

By the time most women receive a PCOS diagnosis, they are presenting with some combination of:

• Irregular, infrequent, or absent menstrual cycles (consequence of step 6)
• Hormonal acne (consequence of step 4)
• Hirsutism (consequence of step 4)
• Androgenic hair loss (consequence of step 4)
• Weight resistance, especially abdominal (consequence of step 1-2)
• Mood disruption, anxiety, depression (multiple pathways)
• Fertility challenges (consequence of step 6)
• Sleep disruption (relationship to multiple steps)

The diagnosis criteria (Rotterdam: 2 of 3 between hyperandrogenism, ovulatory dysfunction, polycystic ovaries) capture the cascade outputs, not the upstream cause. This is why "treating PCOS" without targeting the upstream mechanism often produces short-term symptom relief but no durable change.

The parallel inflammation amplifier

Most PCOS women have measurably elevated low-grade inflammation: higher TNF-alpha, IL-6, hs-CRP, and other inflammatory markers compared to healthy controls (Repaci 2011, Gonzalez 2014). This inflammation runs in parallel to the main cascade and amplifies multiple steps:

• Inflammation worsens insulin resistance at step 1 (inflammatory cytokines impair insulin receptor signaling)
• Inflammation contributes to theca cell dysfunction at step 5
• Inflammation directly drives the sebaceous gland over-activation that produces acne at step 7
• Inflammation in the brain may contribute to the mood symptoms many PCOS women experience

Interventions that act on the inflammation pathway: Mediterranean and anti-inflammatory diet patterns, omega-3 supplementation, turmeric and ginger, adequate vitamin D, regular sleep, and stress management. These compound with the cascade interventions, which is why diet patterns that simultaneously target glycemic load AND inflammation produce broader PCOS improvements than either alone.

Where each intervention acts (full map)

How to use this cascade clinically

The cascade tells you why some interventions stack and why others overlap.

• Upstream-only interventions (metformin, inositol, low-GL diet, strength training) take longer to show visible symptom changes because the cascade has to unwind over weeks-to-months. But they produce durable, system-wide changes.
• Downstream-only interventions (spironolactone, spearmint tea, anti-androgen contraceptives) produce faster visible symptom relief but do not fix the upstream mechanism. Stopping them usually returns symptoms.
• Combined upstream + downstream protocols produce the fastest visible relief (downstream effect) while building durable change (upstream effect). This is the standard PCOS treatment approach.
• Inflammation-targeted interventions (Mediterranean diet, omega-3, turmeric, ginger, sleep, stress management) act on the parallel amplifier and benefit every step of the cascade. They are not optional add-ons; they often determine how well the other interventions work.

The PCOS Meal Planner approach

Most of what we write about food, supplements, and exercise traces back to this cascade. The PCOS Meal Planner targets steps 1 and 2 (the upstream insulin pattern) by default, with food choices that also feed into the inflammation pathway. The supplement guidance built into our system aligns with step-specific evidence — inositol for steps 1 and 6, spearmint for steps 4-5, omega-3 and Mediterranean staples for the inflammation parallel. The whole system is one cascade, one set of interventions, one durable framework.

Frequently asked questions

What is the root cause of PCOS?

Most consistent upstream driver is intrinsic insulin resistance per Stepto 2013 (gold-standard clamp study showed cellular insulin resistance at normal BMI). Genetic component. From cellular IR, the cascade flows: hyperinsulinemia, lower SHBG, higher free testosterone, theca cell androgen overproduction, follicle arrest, visible symptoms. ~70% of PCOS cases.

Why does insulin resistance cause high testosterone in PCOS?

Two mechanisms: (1) hyperinsulinemia suppresses liver SHBG, raising free testosterone fraction; (2) ovarian theca cells have insulin receptors, so high insulin directly stimulates them to make more androgens. Both run in parallel.

What is SHBG and why does it matter for PCOS?

Liver-produced protein that binds testosterone in circulation. Only unbound (free) testosterone is biologically active. Insulin suppresses SHBG production. SHBG is one of the most clinically useful PCOS lab markers — reflects insulin sensitivity better than fasting insulin alone.

How does the PCOS cascade cause irregular periods?

Elevated androgens disrupt FSH-driven follicle maturation. Follicles arrest at small antral stage (polycystic morphology). No dominant follicle = no ovulation = no corpus luteum = no progesterone = endometrium doesn\'t shed on schedule.

Where in the PCOS cascade does inflammation fit?

Parallel amplifier. Most PCOS women have elevated TNF-alpha, IL-6, CRP (Repaci 2011, Gonzalez 2014) independent of weight. Worsens IR at step 1, ovarian dysfunction at step 5, acne presentation at step 7. Anti-inflammatory diet patterns produce broader benefits than glycemic-only patterns.

Where does metformin act in the PCOS cascade?

Upstream at step 1-2. Reduces hepatic gluconeogenesis, improves cellular IR via AMPK, reduces intestinal glucose absorption. Lower insulin demand cascades downstream to restore SHBG and reduce theca stimulation.

Where does inositol act in the PCOS cascade?

Two points: step 1 (insulin signaling second messenger) and step 6 (FSH signaling at the ovary, restores ovulation independent of insulin status). Dual action explains why it works in lean PCOS where IR is less prominent.

Where does spearmint tea act in the PCOS cascade?

Downstream at step 4-5. Rosmarinic acid reduces LH-driven theca cell androgen production, drops free testosterone within 30 days at 2 cups/day (Grant 2010 Phytother Res). Does not act on insulin or SHBG. Combines well with upstream interventions.

Sources and further reading

PCOS pathophysiology and cascade overview

• Diamanti-Kandarakis E, Dunaif A. Insulin resistance and the polycystic ovary syndrome revisited: an update on mechanisms and implications. Endocr Rev. 2012
• Stepto NK et al. Women with PCOS have intrinsic insulin resistance on euglycaemic-hyperinsulaemic clamp. Hum Reprod. 2013
• Dunaif A. Insulin resistance and the polycystic ovary syndrome: mechanism and implications for pathogenesis. Endocr Rev. 1997
• Azziz R et al. Polycystic ovary syndrome. Nat Rev Dis Primers. 2016

SHBG and free testosterone in PCOS

• Nestler JE et al. Suppression of serum insulin by diazoxide reduces serum testosterone in PCOS. J Clin Endocrinol Metab. 1989
• Nestler JE. Role of hyperinsulinemia in the pathogenesis of PCOS. J Reprod Med. 1999
• Wallace IR et al. SHBG as a marker of insulin resistance and metabolic syndrome. Clin Endocrinol. 2013

Ovarian theca cell androgen production

• Nelson VL et al. Augmented androgen production is a stable steroidogenic phenotype of propagated theca cells from polycystic ovaries. Mol Endocrinol. 1999
• Wickenheisser JK et al. Differential activity of the cytochrome P450 17alpha-hydroxylase and steroidogenic acute regulatory protein gene promoters in normal and polycystic ovary syndrome theca cells. J Clin Endocrinol Metab. 2000
• Strauss JF. Some new thoughts on the pathophysiology and genetics of polycystic ovary syndrome. Ann N Y Acad Sci. 2003

Follicle arrest and anovulation

• Franks S et al. Follicular dynamics in the polycystic ovary syndrome. Mol Cell Endocrinol. 2000
• Pellatt L et al. Anti-Mullerian hormone and polycystic ovary syndrome: a mountain too high? Reproduction. 2010

Inflammation in PCOS

• Repaci A, Gambineri A, Pasquali R. The role of low-grade inflammation in the polycystic ovary syndrome. Mol Cell Endocrinol. 2011
• Gonzalez F. Inflammation in polycystic ovary syndrome: underpinning of insulin resistance and ovarian dysfunction. Steroids. 2012
• Duleba AJ, Dokras A. Is PCOS an inflammatory process? Fertil Steril. 2012

Intervention mechanism studies

• Foretz M et al. Metformin: from mechanisms of action to therapies. Cell Metab. 2014
• Unfer V et al. Myo-inositol effects in PCOS women. Eur Rev Med Pharmacol Sci. 2016
• Grant P. Spearmint herbal tea has significant anti-androgen effects in PCOS. Phytother Res. 2010
• Shukla AP et al. Food order has a significant impact on postprandial glucose and insulin levels. Diabetes Care. 2015
• Patten RK et al. Exercise interventions in PCOS: systematic review and meta-analysis. J Clin Med. 2021

PCOS clinical guidelines

• International Evidence-Based Guideline for PCOS (Monash, 2023)
• Endocrine Society 2023 PCOS guideline
• ACOG Practice Bulletin on PCOS
• Cochrane Review: Insulin-sensitising drugs for PCOS (2020)

Patient-facing summaries

• NHS: Causes of PCOS
• Mayo Clinic: PCOS
• NICHD: PCOS causes and risks
• Cleveland Clinic: PCOS
• Office on Women\'s Health: PCOS

How this article was made

Cascade structure draws on the Diamanti-Kandarakis & Dunaif 2012 Endocrine Reviews update on PCOS pathophysiology, the Dunaif 1997 foundational review, and Azziz et al. 2016 in Nature Reviews Disease Primers. Step 1 cellular insulin resistance evidence from Stepto 2013 clamp study. Step 3 SHBG-and-insulin mechanism from Nestler 1989 and Wallace 2013. Step 5 theca cell evidence from Nelson 1999 and Wickenheisser 2000. Inflammation parallel from Repaci 2011 and Gonzalez 2012. Intervention mechanism citations from Foretz 2014 (metformin), Unfer 2016 (inositol), Grant 2010 (spearmint), Shukla 2015 (protein-first eating), Patten 2021 (exercise). Aligned with the 2023 International Evidence-Based Guideline for PCOS, the 2023 Endocrine Society guideline, ACOG Practice Bulletin, and the 2020 Cochrane Review on insulin-sensitising drugs. Updated as new mechanism research is published.

Related reading

• Berberine vs metformin (step 1 interventions compared)
• Inositol vs spearmint tea (step 1+6 vs step 4-5)
• Low GI vs keto (step 2 dietary interventions)
• Mediterranean vs anti-inflammatory (inflammation parallel)
• Worst exercises for PCOS (the cortisol amplifier)
• Why metformin makes you hungry (step 1 intervention side effects)